Association of HBV DNA replication with antiviral treatment outcomes in the patients with early-stage HBV-related hepatocellular carcinoma undergoing curative resection
Abstract Background It remains unclear what the antiviral therapy affects disease-free survival (DFS) and overall survival (OS) of patients with hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) at different tumor stages and baseline HBV DNA levels. In this study, we analyzed the associ...
Main Authors: | Jian-Lin Chen, Xiao-Jun Lin, Qian Zhou, Ming Shi, Sheng-Ping Li, Xiang-Ming Lao |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2016-03-01
|
Series: | Chinese Journal of Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40880-016-0089-z |
Similar Items
-
Clinical Benefit of Antiviral Agents for Hepatocellular Carcinoma Patients With Low Preoperative HBV-DNA Loads Undergoing Curative Resection: A Meta-Analysis
by: Kai-Xuan Liu, et al.
Published: (2021-02-01) -
Antiviral therapy inhibited HBV-reactivation and improved long-term outcomes in patients who underwent radiofrequency ablation for HBV-related hepatocellular carcinoma
by: Jian Liu, et al.
Published: (2023-02-01) -
Chronicles of HBV and the Road to HBV Cure
by: Rukaiya Bashir Hamidu, et al.
Published: (2023-04-01) -
Application and Impact of Antiviral Therapy for Patients with HBV-Related Hepatocellular Carcinoma Receiving Sorafenib and Lenvatinib Treatment
by: I-Cheng Lee, et al.
Published: (2022-10-01) -
Stratification of Hepatocellular Carcinoma Risk Following HCV Eradication or HBV Control
by: Pierre Nahon, et al.
Published: (2021-01-01)